You are here
Type of Miscarriage Treatment Not Important for Future Fertility
The specific type of treatment a woman received after a miscarriage did not appear to affect her chances of giving birth in the future, researchers found.
In a randomized trial, women who received surgical, medical, or "watch-and-wait" management after a first-trimester miscarriage had similar rates of live birth within five years -- about 80% in each group, according to Lindsay Smith, MD, of the East Somerset Research Consortium in England, and colleagues.
"Women can be reassured that after miscarriage their chance of a subsequent live birth is high, irrespective of management method," the researchers reported online in the British Medical Journal.
The standard treatment for miscarriage used to be surgical evacuation of retained products of conception, but now most women receive either no active intervention (watch-and-wait) or pharmacologic treatment with such drugs as mifepristone (Mifeprex) and misoprostol (Cytotec), they said.
Previous findings from the miscarriage treatment (MIST) trial showed that the three strategies resulted in similar rates of gynecological infection. Read more.